Tonix Pharmaceuticals
TNXP
#10216
Rank
A$81.78 M
Marketcap
A$4.21
Share price
-4.08%
Change (1 day)
-83.20%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -A$0.24 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are A$29.1 Million. In 2025 the company made an earning of -A$0.19 Billion a decrease over its 2024 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.24 Billion32.08%
2025 -A$0.19 Billion61.37%
2024 -A$0.12 Billion-36.5%
2023 -A$0.18 Billion5.61%
2022 -A$0.17 Billion21.43%
2021 -A$0.14 Billion82.76%
2020 -A$75.39 Million75.22%
2019 -A$43.03 Million9.52%
2018 -A$39.29 Million23.63%
2017 -A$31.78 Million-45.36%
2016 -A$58.17 Million-19.09%
2015 -A$71.89 Million74.15%
2014 -A$41.28 Million153.99%
2013 -A$16.26 Million
2011 -A$7.85 Million29538.74%
2010 -A$0.03 Million-42.58%
2009 -A$0.05 Million46.05%
2008 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-A$34.69 Million-85.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
A$53.22 M-121.96%๐Ÿ‡บ๐Ÿ‡ธ USA